Pirow Bekker Selected Research

CCX282-B

1/2013	A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.
10/2010	Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pirow Bekker Research Topics

Disease

8	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2022 - 09/2017
5	Vasculitis (Vasculitides) 01/2021 - 09/2017
2	Proteinuria 05/2022 - 09/2015
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 06/2012
2	Inflammation (Inflammations) 01/2015 - 10/2010
2	Rheumatoid Arthritis 03/2013 - 05/2004
2	Crohn Disease (Crohn's Disease) 01/2013 - 10/2010
1	IGA Glomerulonephritis (IGA Nephropathy) 05/2022
1	Unstable Angina 05/2022
1	Glomerulonephritis 04/2020
1	Albuminuria 09/2015
1	Ulcerative Colitis 01/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2010
1	Neutropenia 05/2004
1	Infections 05/2004
1	Injection Site Reaction 05/2004
1	Neoplasms (Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

6	avacopanIBA 05/2022 - 09/2017
5	Anaphylatoxin C5a ReceptorIBA 05/2022 - 09/2017
5	GlucocorticoidsIBA 10/2021 - 09/2017
5	Chemokine ReceptorsIBA 01/2015 - 10/2010
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2019
3	Rituximab (Mabthera)FDA Link 10/2021 - 04/2020
3	Prednisone (Sone)FDA LinkGeneric 01/2021 - 09/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 04/2020
2	CCX140-BIBA 09/2015 - 06/2012
2	LigandsIBA 01/2015 - 10/2010
2	CCX282-BIBA 01/2013 - 10/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020
1	Complement C5a (Complement 5a)IBA 04/2020
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 04/2020
1	Azathioprine (Imuran)FDA LinkGeneric 04/2020
1	Angiotensin Receptor AntagonistsIBA 09/2015
1	AlbuminsIBA 09/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2015
1	CreatinineIBA 09/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2015
1	CC ChemokinesIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	C-Reactive ProteinIBA 01/2013
1	Pharmaceutical PreparationsIBA 10/2010
1	Etanercept (Enbrel)FDA Link 05/2004
1	Methotrexate (Mexate)FDA LinkGeneric 05/2004
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2004
1	OsteoprotegerinIBA 07/2002

Therapy/Procedure

1	Remission Induction 10/2021
1	Therapeutics 05/2004